Nicole Junkermann is a German-born, London-based international entrepreneur and investor, and the founder of NJF Holdings, an international investment company. Her investment focus is primarily on deep tech, healthcare, and biotech, seeking out companies poised for significant global impact. With a keen eye for disruptive technologies, Junkermann has backed a diverse portfolio of early-stage and growth-stage companies across Europe, the US, and Israel. She is recognized for her ability to identify emerging trends and support founders in scaling their businesses. Prior to focusing solely on her investment activities through NJF Holdings, she was involved in various ventures, including co-founding an online sports gaming platform and investing in media and technology.
Nicole Junkermann's work history includes a series of influential roles in various companies. Here is a detailed list of his professional journey:
Established NJF Holdings, an international investment company focusing on venture capital, private equity, and real estate, with a significant emphasis on disruptive technologies in sectors like deep tech, biotech, and healthcare.
Recognized as an early and prominent investor in deep technology and healthcare innovation, backing companies aiming to solve complex global challenges in areas like artificial intelligence, biotechnology, and digital health.
Successfully built and manages a diverse portfolio of investments in innovative companies across key technology hubs including Europe, the United States, and Israel, fostering international collaboration and growth.
Actively contributes to discussions on the future of technology and innovation through speaking engagements, publications, and thought leadership, promoting the positive impact of technological advancements on society and business.
Has a track record of identifying and supporting disruptive companies from their early stages, helping them navigate growth and achieve market leadership.
Harvard Kennedy School - Year 2021
Harvard Business School - Year 2021
Harvard Business School Executive Education - Year 2002
International University of Monaco - Year 1995
Highperformr Signals uncover buying intent and give you clear insights to target the right people at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
The Royal Marsden Cancer Charity raises money solely to support The Royal Marsden, a world-leading cancer centre. They ensure their nurses, doctors, and research teams can provide the very best care and develop life-saving treatments, which are used across the UK and around the world. From funding state-of-the-art equipment and ground-breaking research to creating the best patient environments, they aim to improve the lives of people affected by cancer by investing in a future beyond cancer.
Get verified emails, phone numbers, and LinkedIn profile details
Discover contacts with similar roles, seniority, or companies
Uncover insights like skills, work history, social links, and more
Explore contacts in-depth — from verified emails and phone numbers to LinkedIn activity, job changes, and more — all in one powerful view.
Highperformr AI helps you surface the right people and enrich your CRM with live, accurate contact insights so your teams can connect faster and close smarter.
Thousands of contacts — including decision-makers, influencers, and ICP matches — are just a search away.
Thousands of companies, including, are just a search away.